Literature DB >> 29427483

How to improve long-term outcome after liver transplantation?

François Durand1.   

Abstract

The outcome of liver transplantation has markedly improved in the last 3 decades. Although early post-transplantation outcomes have improved over time, this is not true of the long-term outcome. The majority of late deaths are not related to graft dysfunction, and with the advent of new antiviral agents, recurrence of hepatitis B and hepatitis C after transplantation may no longer represent a source of graft loss and patient's death in the long term. The complications of metabolic syndrome may represent an increasing source of morbidity and mortality after transplantation. This study discusses these modifiable factors associated with late mortality to improve the long-term results of transplantation.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  de novo malignancy; immunosuppression; liver transplantation; metabolic syndrome; viral hepatitis

Mesh:

Substances:

Year:  2018        PMID: 29427483     DOI: 10.1111/liv.13651

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

1.  Is everolimus linked to metabolic syndrome in liver transplant recipients?

Authors:  Εvangelos Cholongitas; Argyro Koukoufiki; Chrysoula Pipili; Nikolaos Antoniadis; Ioannis Fouzas; Anna-Bettina Haidich; Ioannis Goulis
Journal:  Indian J Gastroenterol       Date:  2019-09-12

Review 2.  Management of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.

Authors:  Manhal Izzy; Brett E Fortune; Marina Serper; Nicole Bhave; Andrew deLemos; Juan F Gallegos-Orozco; Cesar Guerrero-Miranda; Shelley Hall; Matthew E Harinstein; Maria G Karas; Michael Kriss; Nicholas Lim; Maryse Palardy; Deirdre Sawinski; Emily Schonfeld; Anil Seetharam; Pratima Sharma; Jose Tallaj; Darshana M Dadhania; Lisa B VanWagner
Journal:  Am J Transplant       Date:  2022-03-31       Impact factor: 9.369

3.  Barriers to Adherence to Medical Care Programs in Liver Transplant Recipients: A Qualitative Study.

Authors:  M S Moayed; M Khatiban; M Nassiri Toosi; M Khodaveisi; A R Soltanian; A Ebadi
Journal:  Int J Organ Transplant Med       Date:  2019

4.  Intravenous Anesthetic Protects Hepatocyte from Reactive Oxygen Species-Induced Cellular Apoptosis during Liver Transplantation In Vivo.

Authors:  Weifeng Yao; Xue Han; Yihan Zhang; Jianqiang Guan; Mian Ge; Chaojin Chen; Shan Wu; Jiaxin Chen; Gangjian Luo; Pinjie Huang; Ziqing Hei
Journal:  Oxid Med Cell Longev       Date:  2018-10-28       Impact factor: 6.543

Review 5.  Medical management of metabolic and cardiovascular complications after liver transplantation.

Authors:  Chiara Becchetti; Melisa Dirchwolf; Vanessa Banz; Jean-François Dufour
Journal:  World J Gastroenterol       Date:  2020-05-14       Impact factor: 5.742

6.  Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution.

Authors:  Diego Costanzo; Maria Bindi; Davide Ghinolfi; Massimo Esposito; Francesco Corradi; Francesco Forfori; Paolo De Simone; Andrea De Gasperi; Gianni Biancofiore
Journal:  BMC Anesthesiol       Date:  2020-01-30       Impact factor: 2.217

7.  Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany.

Authors:  Kerstin Herzer; Martina Sterneck; Martin-Walter Welker; Silvio Nadalin; Gabriele Kirchner; Felix Braun; Christina Malessa; Adam Herber; Johann Pratschke; Karl Heinz Weiss; Elmar Jaeckel; Frank Tacke
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

Review 8.  Current aspects of renal dysfunction after liver transplantation.

Authors:  Mariana P Pacheco; Luiz Augusto Carneiro-D'Albuquerque; Daniel F Mazo
Journal:  World J Hepatol       Date:  2022-01-27

9.  Liver transplantation as a treatment for Wilson's disease with neurological presentation: a systematic literature review.

Authors:  Tomasz Litwin; Jan Bembenek; Agnieszka Antos; Adam Przybyłkowski; Marta Skowrońska; Iwona Kurkowska-Jastrzębska; Anna Członkowska
Journal:  Acta Neurol Belg       Date:  2022-01-26       Impact factor: 2.396

10.  Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients.

Authors:  F Boix; I Legaz; A Minhas; R Alfaro; V Jiménez-Coll; A Mrowiec; H Martínez-Banaclocha; J A Galián; C Botella; M R Moya-Quiles; F Sanchez-Bueno; R Robles; J de la Peña-Moral; P Ramirez; J A Pons; A Minguela; M Muro
Journal:  Clin Exp Immunol       Date:  2020-10-29       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.